Company Overview of PanOptica, Inc.
PanOptica, Inc., a biopharmaceutical company, licenses and develops a portfolio of therapeutics for major ophthalmic diseases. The company focuses on ophthalmology drug development. It provides PAN-90806, a novel small-molecule selective vascular endothelial growth factor receptor antagonist that provides treatment for wet age-related macular degeneration and diabetic retinopathy. The company was founded in 2009 and is based in Bernardsville, New Jersey.
150 Morristown Road
Bernardsville, NJ 07924-2626
Founded in 2009
Key Executives for PanOptica, Inc.
PanOptica, Inc. Key Developments
Similar Private Companies By Industry
|Carmot Therapeutics, Inc.||United States|
|Viamet Pharmaceuticals, Inc.||United States|
|Cocoon Biotech, Inc.||United States|
|Liptis Pharmaceuticals USA, Inc.||United States|
|Good 'n' Natural Manufacturing Corp.||United States|
Recent Private Companies Transactions
April 10, 2014
To contact PanOptica, Inc., please visit panopticapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.